SASCRO Prostate Brachytherapy Guidelines Task Group
These guidelines are a tool to assist medical practitioners in providing evidence based care for patients receiving prostate brachytherapy. They are not implied to be the standard of care or to be inflexible rules and requirements of practice. The sole purpose is to assist practitioners in delivering safe and effective medical care. Variation in the approach toward prostate brachytherapy is common. The guidelines presented here are intended to aid practitioners in managing patients, not to rigidly define process or practice. This guideline was revised collaboratively by a team of radiation oncologists, urologists, medical physicists and radiotherapists who have experience in the delivery of prostate brachytherapy, and endorsed by SASCRO (South African Society for Clinical and Radiation Oncologists). The guidelines are based on the permanent prostate brachytherapy (PPB) and high-dose rate (HDR) brachytherapy guidelines published by ABS (1), ASTRO (2) and ESTRO (3).
